There is no absolute contraindication for the use of bamlanivimab. However, it has not been authorizedÂ for use in the following patient population:

- Hospitalized due to COVID-19 infection

- Requiring oxygen therapy

- Requiring increased oxygen supplementation due to COVID-19 compared to baseline need due to comorbidities unrelated to COVID-19

- Pre-exposure prophylaxis for COVID-19

- Substitution for vaccination

- Areas where resistance to combination or individual therapy for SARS-CoV-2 variants exceeds 5%